首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:European journal of drug metabolism and pharmacokinetics

缩写:EUR J DRUG METAB PH

ISSN:0378-7966

e-ISSN:2107-0180

IF/分区:2.3/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引810
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Alexandra Villalpando-Solórzano,Ashley Marieth Ramirez-Díaz,José Giovanni Navarro-Rangel et al. Alexandra Villalpando-Solórzano et al.
Background and objective: Efavirenz is associated with frequent adverse effects, mainly hepatotoxicity and central nervous system disturbances. The cytochrome P450 enzyme CYP2B6 plays a key role in efavirenz metabolism an...
Tuan Fauziah,Ganesh Kasinathan,Teng Keat Chew et al. Tuan Fauziah et al.
Background: High-dose methotrexate (HDMTX) is an essential agent in hematological malignancies, the use of which is complicated by toxicities related to delayed elimination. Existing thresholds to define delayed eliminati...
Steffen T Ubl,Luc M Arnold,Sophia Krombholz et al. Steffen T Ubl et al.
Background and objective: Cefazolin is widely used for perioperative antibiotic prophylaxis and exhibits high protein binding. As only the unbound fraction exerts antimicrobial activity, understanding protein binding at t...
Satoshi Yokoyama,Michiko Shimada,Junichi Nakagawa et al. Satoshi Yokoyama et al.
Background and objective: Vadadustat, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor, is transported into hepatocytes via OATP1B1, which is encoded by the SLCO1B1 gene. Although interindividual variability ...
Eef Hoeben,Vincent Madelain,Chayan Acharya et al. Eef Hoeben et al.
Background and objective: Calaspargase pegol (CalPEG) is a PEGylated conjugate of L-Asparaginase (L-Asp) and an asparagine specific enzyme approved by the Food and Drug Administration (FDA) as a component of a multi-agent...
Woo-Lee Roh,Wonsuk Shin,Hyounggyoon Yoo et al. Woo-Lee Roh et al.
Background and objectives: To establish pharmacokinetic bioequivalence and assess the safety of a single-dose administration of fixed-dose combination (FDC) tablet containing dapagliflozin 10 mg + pioglitazone 15 mg (JLP-...
Manav Jain,Shaun Kumar,Marco Battaglia et al. Manav Jain et al.
Background and objective: Amiloride, an acid-sensing ion channel (ASIC) blocking agent with demonstrated anti-panic effects in preclinical models, is a promising candidate for rapid treatment of panic attacks. Intranasal ...
Peipei Pan,Yating Jiang,Yuxiao Tu et al. Peipei Pan et al.
Background: Entrectinib, a multi-target tyrosine kinase inhibitor (TKI) against TRK, ROS1, and ALK, is clinically approved for genetically-defined solid tumors. The prevalence of drug-drug interactions (DDIs) with increas...
Yimin Wang,Jiankang Zhao,Bin Cao Yimin Wang
Community-acquired pneumonia (CAP) remains a major global health burden, with antibacterial therapy as the primary treatment strategy. In clinical practice, plasma drug concentrations are often used to guide therapy, yet they may not reliab...
Julian Ananyev,Todd M Myers Julian Ananyev
For over 50 years, ketamine has been approved for anesthesia and indicated for analgesia. In recent years, new clinical uses of ketamine have become increasingly common and continue to emerge. Intramuscular administration is a main route of...